Drug General Information
| Drug Name |
Tolbutamide
|
||
| Synonyms |
Aglicid; Arcosal; Arkozal; Artosin; Artozin; Beglucin; Butamid; Butamide; Butamidum; Diaben; Diabesan; Diabetamid; Diabetol; Diabuton; Diasulfon; Diaval; Dirastan; Dolipol; Drabet; Glyconon; Ipoglicone; Mobenol; Orabet; Oralin; Oramide; Orezan; Orinase; Orinaz; Oterben; Pramidex; Rastinon; Restinon; Tarasina; Tolbet;Tolbusal; Tolbutamid; Tolbutamida; Tolbutamidum; Tolbutone; Toluina; Tolumid; Toluran; Toluvan; Tolylsulfonylbutylurea; Willbutamide; Apotex Brand of Tolbutamide; Aventis Brand of Tolbutamide; BerlinChemie Brand of Tolbutamide; Butamide Brand of Tolbutamide; Hoechst Brand of Tolbutamide; Pfizer Brand of Tolbutamide; TOLBUTAMIDE USP; Tolbutamide Aventis Brand; Tolbutamide Butamide Brand; Tolbutamide Hoechst Brand; Tolbutamide Pfizer Brand; Valdecasas Brand of Tolbutamide; Yamanouchi Brand of Tolbutamide; D 860; HLS 831; T 0891; U 2043; Apo-Tolbutamide; Berlin-Chemie Brand of Tolbutamide; Novo-Butamide; Orinase (TN); Sk-tolbutamide; Tol-Tab; Tolbutamida [INN-Spanish]; Tolbutamidum [INN-Latin]; Tolbutamide [INN:BAN:JAN]; R.A.N. Brand of Tolbutamide; Tolbutamid R.A.N.; Tolbutamide (JP15/USP/INN); N-4-Methylbenzolsulfonyl-N-butylurea; N-4-(Methylbenzolsulfonyl)-n-butylurea; N-Butyl-N'-p-toluenesulfonylurea; N-n-Butyl-N'-tosylurea; N-(4-Methylbenzenesulfonyl)-N'-butylurea; N-(4-Methylphenylsulfonyl)-N'-butylurea; N-(p-Tolylsulfonyl)-N'-butylcarbamide; N-Butyl-N'-(4-methylphenylsulfonyl)urea; N-Butyl-N'-(p-tolylsulfonyl)urea; N-Butyl-N'-toluene-p-sulfonylurea; N-(p-tolylsulfonyl)-N'-n-butylurea; 1-Butyl-3-(4-methylphenylsulfonyl)urea; 1-Butyl-3-(p-methylphenylsulfonyl)urea; 1-Butyl-3-(p-tolylsulfonyl)urea; 1-Butyl-3-(para-tolylsulfonyl) urea; 1-Butyl-3-tosylurea; 1-butyl-3-(4-methylphenyl)sulfonylurea; 1-p-Toluenesulfonyl-3-butylurea; 3-(p-Tolyl-4-sulfonyl)-1-butylurea; 3-(p-tolylsulfonyl)-1-butylurea; 3-[p-Tolyl-4-sulfonyl]-1-butylurea
|
||
| Drug Type |
Small molecular drug
|
||
| Indications |
Non-insulin dependent diabetes [ICD-11: 5A11]
|
Approved
|
|
| Company |
Pharmacia And Upjohn Co
|
||
| Summary |
Tolbutamide is a sulfonylurea used to treat hyperglycemia in patients with type 2 diabetes mellitus.
|
||
| Target |
ATP-binding cassette transporter C8 (ABCC8)
Mechanism of Action: Blocker
|
T91480 | |
|
ATP-binding cassette transporter C9 (ABCC9)
Mechanism of Action: Blocker
|
T02777 | ||
Drug Chemical Infomation and External Links
|
Formula |
C12H18N2O3S
|
| Canonical SMILES |
CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C
|
|
| InChI |
1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)
|
|
| InChIKey |
JLRGJRBPOGGCBT-UHFFFAOYSA-N
|
|
| CAS Number | CAS 64-77-7 | |
| TTD ID | D06OIV | |
| DrugBank ID | DB01124 | |
| PubChem Compound ID | 5505 | |
| PubChem Substance ID |
9357
,
85591
,
640044
,
855782
,
5658513
,
7847446
,
7980810
,
8144417
,
8149557
,
8153385
,
10321470
,
10531694
,
11111857
,
11111858
,
11120087
,
11120575
,
11121063
,
11121572
,
11122052
,
11147170
,
11335516
,
11360755
,
11362641
,
11363341
,
11364689
,
11365203
,
11365903
,
11367251
,
11367765
,
11368465
,
11369813
,
11370553
,
11370554
,
11371678
,
11372854
,
11373366
,
11373934
,
11375413
,
11375927
,
11376627
,
11377976
,
11457019
,
11461727
,
11466218
,
11467338
,
11484736
,
11485776
,
11489026
,
11490415
,
11492173
|
|
| ChEBI ID | CHEBI:27999 | |
| ADReCS Drug ID | BADD_D02240 |
Drug-Food (Herb) Interactions
- Drug
- Foods
- Herbs
- Positive
- Negative
- Possible
- Harmful
- No Effect
| ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship Classification | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship classification |